Logo

... as Thomas Weisel Upgrades ABI Stock

May 24, 2006

NEW YORK, May 24 (GenomeWeb News) - Thomas Weisel today upgraded Applied Biosystems stock to "outperform" from "underperform."

 

Shares in the company were up 3.93 percent, or $1.12, to reach a new 52-week high of $29.62 in mid-afternoon trading today.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.